474 related articles for article (PubMed ID: 28976476)
41. Signal Enhancement of the Dentate Nucleus at Unenhanced MR Imaging after Very High Cumulative Doses of the Macrocyclic Gadolinium-based Contrast Agent Gadobutrol: An Observational Study.
Bjørnerud A; Vatnehol SAS; Larsson C; Due-Tønnessen P; Hol PK; Groote IR
Radiology; 2017 Nov; 285(2):434-444. PubMed ID: 28885891
[TBL] [Abstract][Full Text] [Related]
42. Intravenous injection of gadobutrol in an epidemiological study group did not lead to a difference in relative signal intensities of certain brain structures after 5 years.
Kromrey ML; Liedtke KR; Ittermann T; Langner S; Kirsch M; Weitschies W; Kühn JP
Eur Radiol; 2017 Feb; 27(2):772-777. PubMed ID: 27221561
[TBL] [Abstract][Full Text] [Related]
43. A retrospective cohort evaluation of the effect of multiple administrations of gadopentetate dimeglumine on brain magnetic resonance imaging T1-weighted signal.
Towbin AJ; Zhang B; Dillman JR
Pediatr Radiol; 2021 Mar; 51(3):457-470. PubMed ID: 33399985
[TBL] [Abstract][Full Text] [Related]
44. Pediatric Brain: Repeated Exposure to Linear Gadolinium-based Contrast Material Is Associated with Increased Signal Intensity at Unenhanced T1-weighted MR Imaging.
Flood TF; Stence NV; Maloney JA; Mirsky DM
Radiology; 2017 Jan; 282(1):222-228. PubMed ID: 27467467
[TBL] [Abstract][Full Text] [Related]
45. Signal Increase on Unenhanced T1-Weighted Images in the Rat Brain After Repeated, Extended Doses of Gadolinium-Based Contrast Agents: Comparison of Linear and Macrocyclic Agents.
Jost G; Lenhard DC; Sieber MA; Lohrke J; Frenzel T; Pietsch H
Invest Radiol; 2016 Feb; 51(2):83-9. PubMed ID: 26606548
[TBL] [Abstract][Full Text] [Related]
46. Is There Long-term Signal Intensity Increase in the Central Nervous System on T1-weighted Images after MR Imaging with the Hepatospecific Contrast Agent Gadoxetic Acid? A Cross-sectional Study in 91 Patients.
Kahn J; Posch H; Steffen IG; Geisel D; Bauknecht C; Liebig T; Denecke T
Radiology; 2017 Mar; 282(3):708-716. PubMed ID: 28076722
[TBL] [Abstract][Full Text] [Related]
47. Changes in signal intensity in the dentate nucleus at unenhanced T1-weighted magnetic resonance imaging depending on class of previously used gadolinium-based contrast agent.
Kasper E; Schemuth HP; Horry S; Kinner S
Pediatr Radiol; 2018 May; 48(5):686-693. PubMed ID: 29417165
[TBL] [Abstract][Full Text] [Related]
48. T1 Shortening in the Globus Pallidus after Multiple Administrations of Gadobutrol: Assessment with a Multidynamic Multiecho Sequence.
Kang KM; Choi SH; Hwang M; Yun TJ; Kim JH; Sohn CH
Radiology; 2018 Apr; 287(1):258-266. PubMed ID: 29091750
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of signal intensity changes in dentate nucleus and globus pallidus on magnetic resonance imaging after intrathecal gadolinium-based contrast agent administration.
Asoğlu S; Kılınçer A; Özer H; Topaloğlu ÖF; Cebeci H
Clin Imaging; 2024 May; 109():110140. PubMed ID: 38574605
[TBL] [Abstract][Full Text] [Related]
50. Switching from linear to macrocyclic gadolinium-based contrast agents halts the relative T
Rowe SK; Rodriguez D; Cohen E; Grundy R; Morgan PS; Jaspan T; Dineen RA
J Magn Reson Imaging; 2020 Jan; 51(1):288-295. PubMed ID: 31165554
[TBL] [Abstract][Full Text] [Related]
51. Histology and Gadolinium Distribution in the Rodent Brain After the Administration of Cumulative High Doses of Linear and Macrocyclic Gadolinium-Based Contrast Agents.
Lohrke J; Frisk AL; Frenzel T; Schöckel L; Rosenbruch M; Jost G; Lenhard DC; Sieber MA; Nischwitz V; Küppers A; Pietsch H
Invest Radiol; 2017 Jun; 52(6):324-333. PubMed ID: 28323657
[TBL] [Abstract][Full Text] [Related]
52. High Signal Intensity in Dentate Nucleus on Unenhanced T1-weighted MR Images: Association with Linear versus Macrocyclic Gadolinium Chelate Administration.
Kanda T; Osawa M; Oba H; Toyoda K; Kotoku J; Haruyama T; Takeshita K; Furui S
Radiology; 2015 Jun; 275(3):803-9. PubMed ID: 25633504
[TBL] [Abstract][Full Text] [Related]
53. Gadopentetate but not gadobutrol accumulates in the dentate nucleus of multiple sclerosis patients.
Schlemm L; Chien C; Bellmann-Strobl J; Dörr J; Wuerfel J; Brandt AU; Paul F; Scheel M
Mult Scler; 2017 Jun; 23(7):963-972. PubMed ID: 27679460
[TBL] [Abstract][Full Text] [Related]
54. A multicenter, randomized, controlled, single-blind comparison phase III study to determine the efficacy and safety of gadobutrol 1.0 M versus gadopentetate dimeglumine following single injection in patients referred for contrast-enhanced MRI of the body regions or extremities.
Kuwatsuru R; Takahashi S; Umeoka S; Sugihara R; Zeng M; Huan Y; Peng W; Ma L; Guo L; Teng G; Yao W; Tozaki M; Endo M; Kaji S; Ro T; Tae Hahn S; Chul Kang B; Nishimura H; Sugawara Y; Katakami N; Breuer J; Aitoku Y
J Magn Reson Imaging; 2015 Feb; 41(2):404-13. PubMed ID: 24692302
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of the effect of multiple administrations of gadopentetate dimeglumine or gadoterate meglumine on brain T1-weighted hyperintensity in pediatric patients.
Towbin AJ; Zhang B; Dillman JR
Pediatr Radiol; 2021 Dec; 51(13):2568-2580. PubMed ID: 34286351
[TBL] [Abstract][Full Text] [Related]
56. The Effect of Gadolinium-Based Contrast Agents on Longitudinal Changes of Magnetic Resonance Imaging Signal Intensities and Relaxation Times in the Aging Rat Brain.
Green C; Jost G; Frenzel T; Boyken J; Schwenke C; Pietsch H
Invest Radiol; 2022 Jul; 57(7):453-462. PubMed ID: 35125411
[TBL] [Abstract][Full Text] [Related]
57. Dentate Nucleus Signal Intensity Changes in Children with Adrenoleukodystrophy in Comparison to Primary Brain Tumor with and without Radiotherapy after Gadobutrol Administration.
Ozturk K; Nascene D
J Neuroimaging; 2021 May; 31(3):602-608. PubMed ID: 33783925
[TBL] [Abstract][Full Text] [Related]
58. Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy: comparison of diagnostic performance in myocardial fibrosis between gadobutrol and gadopentetate dimeglumine.
Liu D; Ma X; Liu J; Zhao L; Chen H; Xu L; Sun Z; Fan Z
Int J Cardiovasc Imaging; 2017 Aug; 33(8):1191-1200. PubMed ID: 28289991
[TBL] [Abstract][Full Text] [Related]
59. Gadolinium Presence in the Brain After Administration of the Liver-Specific Gadolinium-Based Contrast Agent Gadoxetate: A Systematic Comparison to Multipurpose Agents in Rats.
Jost G; Frenzel T; Boyken J; Schoeckel L; Pietsch H
Invest Radiol; 2019 Aug; 54(8):468-474. PubMed ID: 30932931
[TBL] [Abstract][Full Text] [Related]
60. Dentate Nucleus Signal Intensity Increases Following Repeated Gadobenate Dimeglumine Administrations: A Retrospective Analysis.
Nguyen NC; Molnar TT; Cummin LG; Kanal E
Radiology; 2020 Jul; 296(1):122-130. PubMed ID: 32343210
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
